• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Graf Global Corp. Announces Closing of $230 Million Initial Public Offering Including Full Exercise of Underwriters' Over-Allotment Option

    6/27/24 3:45:00 PM ET

    THE WOODLANDS, TX, June 27, 2024 (GLOBE NEWSWIRE) -- Graf Global Corp. (the "Company") today announced the closing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The offering was priced at $10.00 per unit, resulting in gross proceeds of $230,000,000.

    The units are listed on the NYSE American LLC ("NYSE") and commenced trading under the ticker symbol "GRAF.U" on June 26, 2024. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants will be exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on NYSE under the symbols "GRAF" and "GRAF WS," respectively. Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of warrants (as well as the exercise of the over-allotment option), $230,000,000 (or $10 per unit sold in the public offering) was placed in trust.

    Graf Global Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to capitalize on the significant experience and relationships of its Chief Executive Officer, Chief Financial Officer and Director, James Graf, but may pursue an initial business combination in any industry or geographic region.

    Cantor Fitzgerald & Co. acted as the sole book-running manager of the offering.

    A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission (the "SEC") on June 25, 2024. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

    The offering is being made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained from Cantor Fitzgerald & Co., Attention: Capital Markets, 499 Park Avenue, 5th Floor New York, New York 10022, or by email at [email protected].

    FORWARD-LOOKING STATEMENTS

    This press release contains statements that constitute "forward-looking statements," including with respect to the proposed initial public offering and the anticipated use of the net proceeds. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement for the Company's offering filed with the SEC. Copies are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

    CONTACT

    James Graf

    Chief Executive Officer, Chief Financial Officer and Director

    Graf Global Corp.

    [email protected]





    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for

    DatePrice TargetRatingAnalyst
    6/20/2025$139.00 → $145.00Buy
    TD Cowen
    6/20/2025$1350.00 → $1600.00Buy
    Pivotal Research Group
    6/20/2025Buy → Hold
    Argus
    6/20/2025$60.00Outperform
    Wolfe Research
    6/20/2025$32.00Outperform
    Macquarie
    6/20/2025Overweight
    Cantor Fitzgerald
    6/20/2025$35.00Outperform
    Wedbush
    6/20/2025$65.00Overweight
    Wells Fargo
    More analyst ratings

    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEVP & CIO Hayden Rachel sold $278,077 worth of shares (6,738 units at $41.27), decreasing direct ownership by 34% to 13,174 units (SEC Form 4)

      4 - SCANSOURCE, INC. (0000918965) (Issuer)

      6/20/25 9:55:05 PM ET
      $SCSC
      Retail: Computer Software & Peripheral Equipment
      Technology
    • EXECUTIVE CHAIRMAN Rabinowitz Matthew sold $8,384,150 worth of shares (54,000 units at $155.26) (SEC Form 4)

      4 - Natera, Inc. (0001604821) (Issuer)

      6/20/25 9:35:04 PM ET
      $NTRA
      Medical Specialities
      Health Care
    • Director Jarosh Rachael was granted 27,777 shares, increasing direct ownership by 50% to 83,851 units (SEC Form 4)

      4 - LIFETIME BRANDS, INC (0000874396) (Issuer)

      6/20/25 9:34:13 PM ET
      $LCUT
      Industrial Machinery/Components
      Consumer Discretionary

    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • TD Cowen reiterated coverage on Itron with a new price target

      TD Cowen reiterated coverage of Itron with a rating of Buy and set a new price target of $145.00 from $139.00 previously

      6/20/25 8:23:52 AM ET
      $ITRI
      Electrical Products
      Industrials
    • Pivotal Research Group reiterated coverage on Netflix with a new price target

      Pivotal Research Group reiterated coverage of Netflix with a rating of Buy and set a new price target of $1,600.00 from $1,350.00 previously

      6/20/25 8:16:01 AM ET
      $NFLX
      Consumer Electronics/Video Chains
      Consumer Discretionary
    • Campbell Soup downgraded by Argus

      Argus downgraded Campbell Soup from Buy to Hold

      6/20/25 8:05:51 AM ET
      $CPB
      Packaged Foods
      Consumer Staples

    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Liberty 77 Capital L.P. bought $5,272,290 worth of shares (907,634 units at $5.81) (SEC Form 4)

      4 - Lionsgate Studios Corp. (0002052959) (Issuer)

      6/20/25 6:15:18 PM ET
      $LION
      Movies/Entertainment
      Consumer Discretionary
    • CHAIRMAN, PRESIDENT, CEO Klein Mark A bought $1,755 worth of shares (100 units at $17.55) (SEC Form 4)

      4 - SB FINANCIAL GROUP, INC. (0000767405) (Issuer)

      6/20/25 5:21:07 PM ET
      $SBFG
      Major Banks
      Finance
    • Amendment: President and COO Tardio Jason bought $9,884 worth of shares (12,512 units at $0.79) (SEC Form 4)

      4/A - IMMUNIC, INC. (0001280776) (Issuer)

      6/20/25 5:16:19 PM ET
      $IMUX
      Biotechnology: Pharmaceutical Preparations
      Health Care

    SEC Filings

    See more
    • SEC Form 144 filed by Venu Holding Corporation

      144 - Venu Holding Corp (0001770501) (Subject)

      6/20/25 9:52:39 PM ET
      $VENU
      Services-Misc. Amusement & Recreation
      Consumer Discretionary
    • Amendment: SEC Form SCHEDULE 13D/A filed by T-Mobile US Inc.

      SCHEDULE 13D/A - T-Mobile US, Inc. (0001283699) (Subject)

      6/20/25 9:47:10 PM ET
      $TMUS
      Telecommunications Equipment
      Telecommunications
    • SEC Form SCHEDULE 13G filed by MKDWELL Tech Inc.

      SCHEDULE 13G - MKDWELL Tech Inc. (0001991332) (Subject)

      6/20/25 9:37:53 PM ET
      $MKDW
      Consumer Electronics/Appliances
      Technology

    Insider purchases explained

    Analytical look into recent insider purchases

    See more
    • Investment Alert: Stock Acquired at Allied Gaming & Entertainment Inc. on Jul 4

      Recently, on July 4, 2024, a significant insider purchase was recorded at Allied Gaming & Entertainment Inc. as Large owner Choi Roy bought $456,750 worth of shares (360,000 units at $1.27), increasing direct ownership by 14% to 2,871,822 units (SEC Form 4). This purchase is notable for the size of the transaction and the percentage increase in direct ownership, indicating a strong belief in the company's future prospects. Insider purchases are generally viewed positively by investors as they signal confidence from those with intimate knowledge of the company's operations. Examining other recent insider transactions at Allied Gaming & Entertainment Inc., we notice a few patterns worth explo

      7/4/24 9:02:21 PM ET
      $AGAE
      Services-Misc. Amusement & Recreation
      Consumer Discretionary
    • Breaking: Stock Acquired at Athira Pharma Inc. on Jun 25

      Recently, on June 25, 2024, Director Romano Kelly A bought $100,051 worth of shares in Athira Pharma Inc. This transaction involved acquiring 42,400 units at $2.36 per share, resulting in a significant increase in direct ownership by 111% to 80,715 units. The purchase was disclosed in the SEC Form 4 filing. Insider buying is often considered a bullish signal as insiders may have insights into the company's future performance. It's essential to analyze this insider purchase in conjunction with previous insider transactions to identify any patterns or trends. Taking into account the information from the SEC filings, several other insiders at Athira Pharma Inc. have also been active in the sto

      6/26/24 3:07:15 PM ET
      $ATHA
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Breaking: Stock Acquired at INmune Bio Inc. on Jun 26

      Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

      6/26/24 2:54:12 PM ET
      $INMB
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care